0001127602-24-009742.txt : 20240312 0001127602-24-009742.hdr.sgml : 20240312 20240312161908 ACCESSION NUMBER: 0001127602-24-009742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240310 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Telman Deborah H CENTRAL INDEX KEY: 0001860008 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24742322 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-10 0000882095 GILEAD SCIENCES, INC. GILD 0001860008 Telman Deborah H GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 EVP, Corporate Affairs & GC 0 Common Stock 2024-03-10 4 M 0 2555 A 14603 D Common Stock 2024-03-10 4 F 0 846 75.12 D 13757 D Restricted Stock Unit 2024-03-10 4 M 0 2555 D Common Stock 2555 29268 D Non-qualified Stock Option (Right to Buy) 75.12 2024-03-10 4 A 0 54980 0 A 2034-03-10 Common Stock 54980 54980 D Restricted Stock Unit 2024-03-10 4 A 0 10815 A Common Stock 10815 40083 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Amy Kim by Power of Attorney for Deborah H. Telman 2024-03-12